Literature DB >> 22043198

Creating a process to standardize regimen order sets within an electronic health record.

Leslie T Busby1, Sheetal Sheth, Jody Garey, Aimee Ginsburg, Thomas Flynn, Michael A Willen, Scott Kruger, Marcus A Neubauer, Michael Kolodziej, David Chang, Eric Scott Palmer, Margaret McGuinness, Nancy J Egerton, Jan Merriman, Eileen B Herbeck, Alison Fetter, Linda Frisk, Mark Sitarik, Roger Anderson, Roy Beveridge.   

Abstract

PURPOSE: US Oncology uses regimen order sets in clinical practice to treat patients. However, the process to assure accuracy and upkeep of these order sets has not been described. The purpose of this project was to evaluate the regimens housed in the electronic health record, iKnowMed, to determine their appropriateness and accuracy.
MATERIALS AND METHODS: US Oncology conducted an audit of its standardized regimen library. A utilization review compared chemotherapy regimens in the library and consolidated order sets on the basis of past utilization. Next, internal and external clinical pharmacists were contracted to verify the accuracy, dose, duration, and cycle length of regimens. References cited in the regimen library were evaluated. New or updated references or clinical practice standards were added or modified when necessary. US Oncology corporate pharmacists reviewed the recommendations and discussed findings with an oversight committee. Final proposals were voted on before being incorporated into iKnowMed. An internal database tracking system tool for all reviewed recommendations was created to track and communicate needed changes to the electronic health record.
RESULTS: Out of 511 regimen order sets, 51 were recommended for removal or consolidation. Of the remaining 460 regimen order sets, all had some administrative changes. Specifically, 75% had title changes, 14% had cycle-related changes, 31% had reference updates, and 13% had dosing updates.
CONCLUSION: Electronic health records systems, such as iKnowMed, can provide standardized order sets for a large oncology network. However, the regimens need to be evaluated routinely using standardized procedures to ensure they are accurate and current.

Entities:  

Year:  2011        PMID: 22043198      PMCID: PMC3140457          DOI: 10.1200/JOP.2011.000275

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  1 in total

1.  Medication safety in the ambulatory chemotherapy setting.

Authors:  Tejal K Gandhi; Sylvia B Bartel; Lawrence N Shulman; Deborah Verrier; Elisabeth Burdick; Angela Cleary; Jeffrey M Rothschild; Lucian L Leape; David W Bates
Journal:  Cancer       Date:  2005-12-01       Impact factor: 6.860

  1 in total
  4 in total

1.  Exploring perceptions and use of the electronic health record by parents of children with autism spectrum disorder: A qualitative study.

Authors:  Ruth A Bush; Aubyn C Stahmer; Cynthia D Connelly
Journal:  Health Informatics J       Date:  2015-05-18       Impact factor: 2.681

2.  Real-World Treatment Patterns and Outcomes Among Patients with Basal Cell Carcinoma Following First-Line Hedgehog Inhibitor Discontinuation.

Authors:  Lance Cowey; Chieh-I Chen; Kathleen M Aguilar; Kalatu Davies; Patrick R LaFontaine; Matthew G Fury; Timothy Bowler; Asieh Golozar; Jessica J Jalbert
Journal:  Dermatol Ther (Heidelb)       Date:  2022-05-04

3.  Effects of Pharmacist-Led Clinical Pathway/Order Sets on Cancer Patients: A Systematic Review.

Authors:  Zhiyuan Tan; Zhiheng Yu; Ken Chen; Wei Liu; Rongsheng Zhao
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

Review 4.  Identifying options for oncology therapy regimen codification to improve standardization-combined results of an expert panel and a review.

Authors:  Robert Terkola; Christophe Bardin; Garbiñe Lizeaga Cundin; Nadine Zeinab; Mirjam Crul
Journal:  J Clin Pharm Ther       Date:  2021-03-09       Impact factor: 2.512

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.